Geron Corp. (GERN)
1.59
+0.11
(+7.43%)
USD |
NASDAQ |
Sep 02, 16:00
1.59
0.00 (0.00%)
After-Hours: 06:42
Geron Cash and Short Term Investments (Quarterly) : 302.74M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 302.74M |
| March 31, 2026 | 314.28M |
| December 31, 2025 | 359.80M |
| September 30, 2025 | 382.41M |
| June 30, 2025 | 389.85M |
| March 31, 2025 | 398.74M |
| December 31, 2024 | 408.43M |
| September 30, 2024 | 341.63M |
| June 30, 2024 | 363.86M |
| March 31, 2024 | 444.17M |
| December 31, 2023 | 334.81M |
| September 30, 2023 | 314.06M |
| June 30, 2023 | 371.91M |
| March 31, 2023 | 381.11M |
| December 31, 2022 | 173.11M |
| September 30, 2022 | 195.15M |
| June 30, 2022 | 219.65M |
| March 31, 2022 | 167.03M |
| December 31, 2021 | 184.09M |
| September 30, 2021 | 176.48M |
| June 30, 2021 | 198.60M |
| March 31, 2021 | 211.39M |
| December 31, 2020 | 196.64M |
| September 30, 2020 | 227.99M |
| June 30, 2020 | 219.11M |
| Date | Value |
|---|---|
| March 31, 2020 | 132.39M |
| December 31, 2019 | 139.60M |
| September 30, 2019 | 138.88M |
| June 30, 2019 | 152.76M |
| March 31, 2019 | 152.25M |
| December 31, 2018 | 163.56M |
| September 30, 2018 | 166.62M |
| June 30, 2018 | 161.20M |
| March 31, 2018 | 90.05M |
| December 31, 2017 | 94.95M |
| September 30, 2017 | 97.16M |
| June 30, 2017 | 95.11M |
| March 31, 2017 | 99.56M |
| December 31, 2016 | 115.11M |
| September 30, 2016 | 108.81M |
| June 30, 2016 | 110.87M |
| March 31, 2016 | 109.92M |
| December 31, 2015 | 114.04M |
| September 30, 2015 | 119.95M |
| June 30, 2015 | 138.28M |
| March 31, 2015 | 146.10M |
| December 31, 2014 | 151.71M |
| September 30, 2014 | 126.67M |
| June 30, 2014 | 141.13M |
| March 31, 2014 | 145.99M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Precigen, Inc. | 38.21M |
| Editas Medicine, Inc. | 211.64M |
| Agenus, Inc. | 18.74M |
| Amgen, Inc. | 13.99B |
| Anika Therapeutics, Inc. | 38.41M |